Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026)
Baxter International's (BAX) quarterly Total Non-Current Liabilities came in at $12.5 billion in Q1 2026, down 4.49% year-on-year from $13.1 billion in Q1 2025, and down 1.01% on a QoQ basis from $12.7 billion in Q4 2025.
Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Total Non-Current Liabilities data on file, last reported at $12.5 billion in Q1 2026.
- On a quarterly basis, Total Non-Current Liabilities fell 4.49% year-over-year to $12.5 billion in Q1 2026; TTM through Mar 2026 was $12.5 billion, a 4.49% decrease from a year earlier, with the FY2025 full-year figure at $12.7 billion, down 28.37% from the prior year.
- Total Non-Current Liabilities for Q1 2026 stood at $12.5 billion, down from $12.7 billion in the prior quarter.
- Over the last five years, Total Non-Current Liabilities for BAX reached as high as $21.2 billion in Q1 2022 and fell as low as $12.5 billion in Q1 2026.
- Historically, Total Non-Current Liabilities has averaged $17.5 billion across 5 years, with a median of $17.9 billion in 2024.
- Across the five-year window, Total Non-Current Liabilities surged 126.58% in 2022 and slipped 28.37% in 2025, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $20.5 billion in 2022, then slipped by 10.4% to $18.4 billion in 2023, then fell by 3.94% to $17.7 billion in 2024, then declined by 28.37% to $12.7 billion in 2025, then fell by 1.01% to $12.5 billion in 2026.
- Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $12.5 billion in Q1 2026, $12.7 billion in Q4 2025, and $12.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 6.48 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 48.37 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 17.13 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 941.16 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 996.30 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 4.24 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 8.65 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 2.06 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 12.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.54 Bn |
| Dec 31, 2025 | 12.67 Bn |
| Sep 30, 2025 | 12.73 Bn |
| Jun 30, 2025 | 12.66 Bn |
| Mar 31, 2025 | 13.13 Bn |
| Dec 31, 2024 | 17.68 Bn |
| Sep 30, 2024 | 17.47 Bn |
| Jun 30, 2024 | 17.01 Bn |
| Mar 31, 2024 | 17.90 Bn |
| Dec 31, 2023 | 18.41 Bn |
| Sep 30, 2023 | 20.71 Bn |
| Jun 30, 2023 | 20.63 Bn |
| Mar 31, 2023 | 20.50 Bn |
| Dec 31, 2022 | 20.54 Bn |
| Sep 30, 2022 | 20.32 Bn |
| Jun 30, 2022 | 20.66 Bn |
| Mar 31, 2022 | 21.16 Bn |
| Dec 31, 2021 | 21.91 Bn |
| Sep 30, 2021 | 9.37 Bn |
| Jun 30, 2021 | 9.52 Bn |